23 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp03638 | Lactoferricin B | FKCRRWQWRMKKLGA | Temporins family | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | Kelly | Brain tumor | IC50 : 15.5 µM |
| dbacp03639 | Lactoferricin B | FKCRRWQWRMKKLGA | Temporins family | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | IMR-32 | Brain tumor | IC50 : 29 µM |
| dbacp03640 | Lactoferricin B | FKCRRWQWRMKKLGA | Temporins family | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SK-N-DZ | Brain tumor | IC50 : 37 µM |
| dbacp03641 | Lactoferricin B | FKCRRWQWRMKKLGA | Temporins family | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SHEP-12 | Brain tumor | IC50 : 45 µM |
| dbacp03642 | Lactoferricin B | FKCRRWQWRMKKLGA | Temporins family | Inducing mitochondria-dependent apoptosis | MTT/MTS assay | SH-SY-5Y2 | Brain tumor | IC50 : 60 µM |
| dbacp06248 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | SW-1116 | Colorectal cancer | 57.62 inhibition ratio at 50 µg/ml |
| dbacp06249 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | SMMC-7721 | Liver cancer | 52.77 inhibition ratio at 50 µg/ml |
| dbacp06250 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | 52.32 inhibition ratio at 50 µg/ml |
| dbacp06251 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HepG-2 | Liver cancer | 50.90 inhibition ratio at 50 µg/ml |
| dbacp06252 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | BGC-823 | Gastric cancer | 48.19 inhibition ratio at 50 µg/ml |
| dbacp06253 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | 45.62 inhibition ratio at 50 µg/ml |
| dbacp06254 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HL7702 | Liver cancer | 37.22 inhibition ratio at 50 µg/ml |
| dbacp06255 | Temporin-La | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HEK-293T | Renal cancer | 30.82 inhibition ratio at 50 µg/ml |
| dbacp06257 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | SW-1116 | Colorectal cancer | 62.73 inhibition ratio at 50 µg/ml |
| dbacp06258 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | SMMC-7721 | Liver cancer | 59.37 inhibition ratio at 50 µg/ml |
| dbacp06259 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HeLa | Cervical cancer | 56.81 inhibition ratio at 50 µg/ml |
| dbacp06260 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HepG-2 | Liver cancer | 55.98 inhibition ratio at 50 µg/ml |
| dbacp06261 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | BGC-823 | Gastric cancer | 50.85 inhibition ratio at 50 µg/ml |
| dbacp06262 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | A-549 | Lung cancer | 50.64 inhibition ratio at 50 µg/ml |
| dbacp06263 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HL7702 | Liver cancer | 37.00 inhibition ratio at 50 µg/ml |
| dbacp06264 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | HEK-293T | Renal cancer | 30.90 inhibition ratio at 50 µg/ml |
| dbacp06265 | Temporin-Las | LLRHVVKILEKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | MEC | Breast cancer | 24.15 inhibition ratio at 50 µg/ml |
| dbacp06266 | Temporin-Las | LLRHVVKILSKYL | Temporins family | Cell membrane disintegration | MTT/MTS assay | MEC | Breast cancer | 27.99 inhibition ratio at 50 µg/ml |